November 05, 2025

Get In Touch

Parathyroid Hormone Levels In Obese Kids Independent Of Vitamin D Status: Study

Vitamin D and Parathyroid Hormone in Pediatric Obesity

Vitamin D and Parathyroid Hormone in Pediatric Obesity

Suboptimal vitamin D status and high levels of parathyroid hormone are a common feature in the pediatric population with severe obesity, suggests the findings of a new study. Further, in these patients, the seasonal variations in 25(OH)D were not modified, and parathyroid hormone levels remained increased throughout the year, but without any seasonal variations. The findings have recently been published in the European Journal of Pediatrics.

Though obesity has been associated with lower 25(OH)D and higher PTH levels, the relation among vitamin D and PTH through a natural year in children with obesity is partially known to date.

The objective of this study was to analyze the prevalence of hypovitaminosis D in children with severe obesity. The researchers hypothesized that severe obesity could modify the seasonal variations in 25(OH)D and PTH serum levels throughout the year.

The study design consisted of a cross-sectional clinical and blood testing (calcium, phosphorus, 25(OH)D, and PTH) was carried out in 282 patients with severe obesity, aged 7.2–15.2 years. A control group was recruited (348 healthy children, aged 7.1–14.9 years). The criteria of the US Endocrine Society were used for the definition of hypovitaminosis D.

On data analysis, the following facts emerged:

  • Vitamin D deficiency and hyperparathyroidism were more frequent (p < 0.05) in the obesity group (44.5% vs. 11.5% and 22.4% vs. 3.9%, respectively).
  • There were seasonal variations in 25(OH)D levels in the obesity group, but they were lower (p < 0.05) with respect to the control group.
  • In contrast, PTH levels were higher (p < 0.05) in the obesity group with respect to the control group, but there were no significant seasonal variations in PTH levels.

"Parathyroid hormone levels in obesity are independent of vitamin D status and do not appear to represent secondary hyperparathyroidism," wrote the team.

For the full article, follow the link: https://doi.org/10.1007/s00431-020-03857-4

Primary source: European Journal of Pediatrics

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!